Fundraising FoxVial
San Francisco, US · 3 known investors
Find your way into Vial
Sign up to see every warm intro you have to Vial
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vial team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vial develops first- and best-in-class biologics — including RNA, antibody, and small molecule programs — using AI-driven target discovery, molecule design, and high-throughput experimental validation, focused on immunology and inflammatory disorders. It also runs programs through its own clinical trial platform for automated clinical trials.
Founders & leadership
Investors · 3
ATEL Ventureslisted by ATEL VenturesSan Francisco
How we know: ATEL Ventures's portfolio page · Not right? Tell us
.png)
Byers Capitalreported
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Vial do?
- Vial develops first- and best-in-class biologics — including RNA, antibody, and small molecule programs — using AI-driven target discovery, molecule design, and high-throughput experimental validation, focused on immunology and inflammatory disorders. It also runs programs through its own clinical trial platform for automated clinical trials.
- Who founded Vial?
- Vial was founded by Simon Burns.
- Who are Vial's investors?
- Vial's investors include ATEL Ventures, General Catalyst, Byers Capital.
- Where is Vial headquartered?
- Vial is headquartered in San Francisco, US.